ARCHIVES

NKTR-102 Shows 29 Percent Response in Phase II Study

This article is from The Cancer Letter archive.

Vol. 34 No. 9 | September 30, 2011

Download PDF Visit The Full Archive

Related Articles

NIH Reauthorization Threatened By Fetal Research Issue

October 5, 1990

In Brief: Mass. Selects Hoh As Health Commissioner; Komen Foundation Selects Research Fellows

August 8, 1997

Fifty-Nine CCOP Awards Made; Payline 250, Six Funded as Exceptions

May 27, 1983

Study Uncovers New Mechanism In Class of Chemotherapy Drugs

November 30, 2012

ACCC T Discuss Personnel, Fund Sources, Clinical Research At Annual Meeting

January 9, 1976

Amgen Halts Phase III Trial Of Ganitumab Plus Gemcitabine

August 31, 2012